Vascular rhexis: Loss of integrity of coronary vasculature in mice subjected to myocardial infarction

Experimental Biology and Medicine

Volumn 235, Issue 8, 2010, Pages 966-973

  French, Christopher J ^a   Zaman, A K M T ^a   Kelm Jr , Robert J ^a   Spees, Jeffrey L ^a   Sobel, Burton E ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Heart failure; Ischemia; Microcirculation; Myocardial infarction; Necrosis; PAI 1; Remodeling; Vascular rhexis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; HEMOGLOBIN; MYOGLOBIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CELL DEATH; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; HEART INFARCTION; HEART MUSCLE CELL; HOMOGENATE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ANGIOGENESIS; ANIMAL; C57BL MOUSE; CORONARY BLOOD VESSEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; ISCHEMIA; METABOLISM; MICROCIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CORONARY VESSELS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEMORRHAGE; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MICE; MICE, INBRED C57BL; MICROCIRCULATION; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

MUS;

EID: 77955681866     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010108     Document Type: Article

References (27)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20 (Pubitemid 36050955)
2. Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation 2000;102(Suppl. 4):pIV14-23
3. Dargie H. Heart failure post-myocardial infarction: a review of the issues. Heart 2005;91(Suppl. 2):ii3-6; discussion ii31, ii43-38
4. Hellermann JP, Goraya TY, Jacobsen SJ, Weston SA, Reeder GS, Gersh BJ, Redfield MM, Rodeheffer RJ, Yawn BP, Roger VL. Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol 2003;157:1101-7
5. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72
6. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 2008;118:2057-62
7. Zaman AK, Fujii S, Schneider DJ, Taatjes DJ, Lijnen HR, Sobel BE. Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants. Histochem Cell Biol 2007;128:135-45 (Pubitemid 47197925)
8. Zaman AK, French CJ, Sobel BE. Vascular rhexis: a pathogenic factor potentially contributing to negative remodeling and adverse consequences after myocardial infarction. Circulation 2009;120:S1106-2009 (abstract presented at American Heart Association Scientific Sessions, Orlando, FL)
9. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardio 2009;54:281-92
10. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508
11. Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 2001;22:729-39 (Pubitemid 32625230)
12. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-62
13. Engler RL, Schmid-Schonbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111
14. Ambrosio G, Tritto I. 'Reperfusion injury: experimental evidence and clinical implications'. Am Heart J 1999;138:S69-75
15. Zaman AK, French CJ, Schneider DJ, Sobel BE. A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) in the heart. Exp Biol Med (Maywood) 2009;234:246-54
16. French CJ, Spees JL, Zaman AK, Taatjes DJ, Sobel BE. The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion. FASEB J 2009;23:1177-85
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54
18. Virag JI, Murry CE. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 2003;163:2433-40
19. Bresnahan GF, Roberts R, Shell WE, Ross J Jr, Sobel BE. Deleterious effects due to hemorrhage after myocardial reperfusion. Am J Cardiol 1974;33:82-6
20. Kawano H, Hayashida T, Ohtani H, Kanda M, Koide Y, Baba T, Toda G, Shimokawa I, Yano K, Okada R. Histopathological findings of the no-reflow phenomenon following coronary intervention for acute coronary syndrome. Int Heart J 2005;46:327-32
21. Xu Z, Castellino FJ, Ploplis VA. Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture. Blood 2010;115:2038-47
22. Das H, George JC, Joseph M, Das M, Abdulhameed N, Blitz A, Khan M, Sakthivel R, Mao HQ, Hoit BD, Kuppusamy P, Pompili VJ. Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One 2009;4:e7325
23. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-9 (Pubitemid 32803022)
24. Leone AM, Galiuto L, Garramone B, Rutella S, Giannico MB, Brugaletta S, Perfetti M, Liuzzo G, Porto I, Burzotta F, Niccoli G, Biasucci LM, Leone G, Rebuzzi AG, Crea F. Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the Rigenera study). Am J Cardiol 2007;100:397-403 (Pubitemid 47094686)
25. Iwanaga K, Takano H, Ohtsuka M, Hasegawa H, Zou Y, Qin Y, Odaka K, Hiroshima K, Tadokoro H, Komuro I. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun 2004;325:1353-9 (Pubitemid 39535912)
26. Hale SL, Dave RH, Kloner RA. Regional hypothermia reduces myocardial necrosis even when instituted after the onset of ischemia. Basic Res Cardiol 1997;92:351-7
27. Hale SL, Kloner RA. Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia. Am J Physiol 1997;273:H220-7